People are being invited to start 2024 as they mean to go on by signing-up for Cancer Research UK’s Race for Life.

The charity’s much-loved event, which raise funds for life-saving research, is returning to Huddersfield. Anyone who joins this January can claim 50% off the entry fee as part of a special ‘early bird’ sale by using the code RACE24NY.

Every year around 32,800 people are diagnosed with cancer in Yorkshire and the Humber. Money raised at Race for Life enables scientists to find new ways to prevent, diagnose and treat cancer – moving closer to a world where everyone can live longer, better lives free from the fear of cancer.   

The 5k event will be held at Greenhead Park on Sunday June 23.

Cancer Research UK’s Race for Life, in partnership with headline sponsor Standard Life, part of Phoenix Group, raises millions of pounds every year across the UK to help beat cancer by funding crucial research.   

Jane Bullock, Cancer Research UK’s spokesperson in Yorkshire, said: “No matter how cancer affects us, life is worth racing for.

“Sadly nearly one in two of us will get cancer in our lifetime but Race for Life has the power not only to transform lives, but to save them. We’re proud that Race for Life has already helped double survival rates in the UK.

“We’d love for as many people as possible across Yorkshire and beyond to join us at Race for Life. There is a race for everyone and we mean everyone. Walk, jog, run or take on the course however it suits best. It’s a chance to feel the power of moving together with fellow Race for Lifers and have fun with it.

“January is the perfect time to commit to getting a little more active. Whether people are living with cancer, taking part in honour of or in memory of a loved one with cancer, in it for the medals or just for the fun of fundraising, there is a place for everyone.”

Since it began in 1994, more than 10 million people have taken part in Race for Life, funding 30 years of hope and progress. Money raised has helped develop radiotherapy which benefits more than 130,000 people with cancer in the UK every year.

Cancer Research UK funded scientists led the development of the Human Papillomavirus Virus vaccine, which is expected to prevent almost 90 per cent of cervical cancers in the UK.

The charity also funded many large clinical trials looking at the effectiveness of the drug tamoxifen and the research shaped the way the drug is used to treat breast cancer today.

To enter, visit